Re: Nationwide prevalence of lymph node metastases in Gleason score 3 + 3 = 6 prostate cancer

Pathology

Volumn 47, Issue 4, 2015, Pages 394-

  Kryvenko, Oleksandr N ^a   Epstein, Jonathan I ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; HUMAN; LYMPH NODE METASTASIS; MALE; PATHOLOGY; PROSTATE TUMOR;

ADENOCARCINOMA; HUMANS; LYMPHATIC METASTASIS; MALE; PROSTATIC NEOPLASMS;

EID: 84941344746     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0000000000000263     Document Type: Article

References (10)

1. 1. Liu, J., Lichtensztajn, D.Y., Gomez, S.L., et al. Nationwide prevalence of lymph node metastases in Gleason score 3 + 3 = 6 prostate cancer. Pathology 46 (2014), 306–310.
2. 2. Ross, H.M., Kryvenko, O.N., Cowan, J.E., et al. Do adenocarcinomas of the prostate with Gleason score (GS)
3. 3. Kweldam CF, Wildhagen MF, Bangma CH, et al. Disease-specific death and metastasis do not occur in patients with Gleason score
4. 4. Kryvenko, O.N., Gupta, N.S., Virani, N., et al. Gleason score 7 adenocarcinoma of the prostate with lymph node metastases: analysis of 184 radical prostatectomy specimens. Arch Pathol Lab Med 137 (2013), 610–617.
5. 5. Epstein, J.I., Allsbrook, N.S. Jr., Amin, M.B., et al. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 29 (2005), 1228–1242.
6. 6. Brimo, F., Schultz, L., Epstein, J.I., The value of mandatory second opinion pathology review of prostate needle biopsy interpretation before radical prostatectomy. J Urol 184 (2010), 126–130.
7. 7. Latour, M., Amin, M.B., Billis, A., et al. Grading of invasive cribriform carcinoma on prostate needle biopsy: an interobserver study among experts in genitourinary pathology. Am J Surg Pathol 32 (2008), 1532–1539.
8. 8. Samaratunga, H., Montironi, R., True, L., et al. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 1: specimen handling. Mod Pathol 24 (2011), 6–15.
9. 9. Kryvenko, O.N., Carter, H.B., Trock, B.J., et al. Biopsy criteria for determining appropriateness for active surveillance in the modern era. Urology 83 (2014), 869–874.
10. 10. Sundi, D., Kryvenko, O.N., Carter, H.B., et al. Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men. J Urol 191 (2014), 60–67.